Claus, I. (2025) “Metabolomics for Distinguishing Cardiovascular Risk in Rheumatoid Arthritis Across Different Disease-Modifying Antirheumatic Drug Therapies”, Journal of Clinical Medicine Research, 17(2), pp. 89–96. doi:10.14740/jocmr6145.